The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
In vivo fluorescence imaging: success in preclinical imaging paves the way for clinical applications
Open accessAbstract
Advances in diagnostic imaging have provided unprecedented opportunities to detect diseases at early stages and with high reliability. Diagnostic imaging is also crucial to monitoring the progress or remission of disease and thus is often the central basis of therapeutic decision-making. Currently, several diagnostic imaging modalities (computed tomography, magnetic resonance imaging, and positron emission tomography, among others) are routinely used in clinics and present their own advantages and limitations. In vivo near-infrared (NIR) fluorescence imaging has recently emerged as an attractive imaging modality combining low cost, high sensitivity, and relative safety. As a preclinical tool, it can be used to investigate disease mechanisms and for testing novel diagnostics and therapeutics prior to their clinical use. However, the limited depth of tissue penetration is a major challenge to efficient clinical use. Therefore, the current clinical use of fluorescence imaging is limited to a few applications such as image-guided surgery on tumors and retinal angiography, using FDA-approved dyes. Progress in fluorophore development and NIR imaging technologies holds promise to extend their clinical application to oncology, cardiovascular diseases, plastic surgery, and brain imaging, among others. Nanotechnology is expected to revolutionize diagnostic in vivo fluorescence imaging through targeted delivery of NIR fluorescent probes using antibody conjugation. In this review, we discuss the latest advances in in vivo fluorescence imaging technologies, NIR fluorescent probes, and current and future clinical applications. Graphical Abstract
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Optical properties of biological tissues: A review
Jacques, S. L. (2013) · Physics in Medicine and Biology · doi:10.1088/0031-9155/58/11/r37 · Cited by 4,008
Quantum dots versus organic dyes as fluorescent labels
Resch-Genger, U., Grabolle, M., Cavaliere-Jaricot, S., Nitschke, R., & Nann, T. (2008) · Nature Methods · doi:10.1038/nmeth.1248 · Cited by 3,833
Near-infrared fluorophores for biomedical imaging
Hong, G., Antaris, A. L., & Dai, H. (2017) · Nature Biomedical Engineering · doi:10.1038/s41551-016-0010 · Cited by 2,985
Shimomura, O., Johnson, F. H., & Saiga, Y. (1962) · Journal of Cellular and Comparative Physiology · doi:10.1002/jcp.1030590302 · Cited by 2,384
Primary structure of the Aequorea victoria green-fluorescent protein
Prasher, D. C., Eckenrode, V. K., Ward, W. W., Prendergast, F. G., & Cormier, M. J. (1992) · Gene · doi:10.1016/0378-1119(92)90691-h · Cited by 2,177
Development of therapeutic antibodies for the treatment of diseases
Lu, R.-M., Hwang, Y.-C., Liu, I.-J., Lee, C.-C., Tsai, H.-Z., Li, H.-J., & Wu, H.-C. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-019-0592-z · Cited by 2,085
Luminescent quantum dots for multiplexed biological detection and imaging
Chan, W. C. W., Maxwell, D. J., Gao, X., Bailey, R. E., Han, M., & Nie, S. (2002) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(02)00282-3 · Cited by 2,068
Shedding light onto live molecular targets
Weissleder, R., & Ntziachristos, V. (2003) · Nature Medicine · doi:10.1038/nm0103-123 · Cited by 1,909
A small-molecule dye for NIR-II imaging
Antaris, A. L., Chen, H., Cheng, K., Sun, Y., Hong, G., Qu, C., Diao, S., Deng, Z., Hu, X., Zhang, B., et al. (2016) · Nature Materials · doi:10.1038/nmat4476 · Cited by 1,778
Cited by
Hang, Y., Wang, A., & Wu, N. (2024) · Chemical Society Reviews · doi:10.1039/d3cs00793f · Cited by 473
Nanoparticles in cancer theragnostic and drug delivery: A comprehensive review
Al-Thani, A. N., Jan, A. G., Abbas, M., Geetha, M., & Sadasivuni, K. K. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122899 · Cited by 323
Emerging insights in senescence: pathways from preclinical models to therapeutic innovations
Mansfield, L., Ramponi, V., Gupta, K., Stevenson, T., Mathew, A. B., Barinda, A. J., Herbstein, F., & Morsli, S. (2024) · npj Aging · doi:10.1038/s41514-024-00181-1 · Cited by 88
Near-infrared fluorescent Aza-BODIPY dyes: Rational structural design and biomedical imaging
Zhao, B., Liao, L., Zhu, Y., Hu, Z., & Wu, F. (2023) · Journal of Luminescence · doi:10.1016/j.jlumin.2023.120099 · Cited by 31
Wang, Y., Zhao, G., Liu, Y., Wang, R., Xing, Y., Dou, K., & Yu, F. (2025) · Sensors and Actuators B: Chemical · doi:10.1016/j.snb.2024.137005 · Cited by 16
Metadata
- Authors
- Refaat, A., Yap, M. L., Pietersz, G., Walsh, A. P. G., Zeller, J., del Rosal, B., Wang, X., & Peter, K.
- Venue
- Journal of Nanobiotechnology
- Published
- 2022-10-15
- Volume
- 20
- Issue
- 1
- Pages
- 450-450
- ISSN
- 1477-3155 (ISSN-L)
- OpenAlex
- W4306315468
- Cited by
- 266
- References
- 139
- FWCI
- 26.52
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: In vivo fluorescence imaging: success in preclinical imaging paves the way for clinical applications. https://app.cochat.ai/papers/10.1186/s12951-022-01648-7
- The paper
- Refaat, A., Yap, M. L., Pietersz, G., Walsh, A. P. G., Zeller, J., del Rosal, B., Wang, X., & Peter, K. (2022). In vivo fluorescence imaging: success in preclinical imaging paves the way for clinical applications. Journal of Nanobiotechnology. https://doi.org/10.1186/s12951-022-01648-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
